Literature DB >> 15801246

A modified pulmonary index score with predictive value for pediatric asthma exacerbations.

Christopher L Carroll1, Anand K Sekaran, Trudy J Lerer, Craig M Schramm.   

Abstract

BACKGROUND: Several clinical asthma scores have been derived from combinations of physical findings in pediatric asthmatic patients.
OBJECTIVE: To test the reproducibility and validity of one such score, the Modified Pulmonary Index Score (MPIS), and to evaluate its predictive value in children hospitalized for asthma.
METHODS: In the MPIS, 6 categories are evaluated: oxygen saturation, accessory muscle use, inspiratory to expiratory flow ratio, degree of wheezing, heart rate, and respiratory rate. For each of these 6 measurements or observations, a score of 0 to 3 is assigned. To evaluate the reproducibility of the MPIS, inpatients with status asthmaticus were examined by an attending physician, nurse, and respiratory therapist who were blinded to the other observers' scores. To evaluate the validity of the MPIS as a scale of severity of illness in asthmatic patients, the score at admission was compared with selected outcomes in the same patients.
RESULTS: A total of 30 patients participated in this study (mean +/- SD age, 7.6 +/- 5.5 years). Our finding revealed that the MPIS is highly reproducible with a high degree of interrater reliability across caregiver groups (physician to nurse: r = 0.98; 95% confidence interval [CI], >0.96; physician to respiratory therapist: r = 0.95; 95% CI, >0.92; nurse to respiratory therapist: r = 0.94; 95% CI, >0.90). The admission MPIS positively correlated with intensive care unit admission (P < .001), days of continuous albuterol therapy (P = .002), days of supplemental oxygen (P = .002), and length of hospital stay (P = .004).
CONCLUSIONS: The MPIS is a highly reproducible and valid indicator of severity of illness in children with asthma. To our knowledge, this is the first pediatric clinical asthma score demonstrated to be reproducible across groups of health care professionals who treat pediatric patients with asthma.

Entities:  

Mesh:

Year:  2005        PMID: 15801246     DOI: 10.1016/S1081-1206(10)60987-8

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  13 in total

1.  Comparison of levalbuterol and racemic albuterol based on cardiac adverse effects in children.

Authors:  Laura L Bio; Vincent J Willey; Cathy Y Poon
Journal:  J Pediatr Pharmacol Ther       Date:  2011-07

2.  Rhinovirus and serum IgE are associated with acute asthma exacerbation severity in children.

Authors:  David B Kantor; Nicole Stenquist; Molly C McDonald; Blake J Schultz; Marissa Hauptman; Craig D Smallwood; Kyle A Nelson; Matthew S Perzanowski; Elizabeth C Matsui; Wanda Phipatanakul; Joel N Hirschhorn
Journal:  J Allergy Clin Immunol       Date:  2016-06-15       Impact factor: 10.793

3.  A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit.

Authors:  Andrew G Miller; Kaitlyn E Haynes; Rachel M Gates; Kanecia O Zimmerman; Travis S Heath; Kathleen W Bartlett; Heather S McLean; Kyle J Rehder
Journal:  Respir Care       Date:  2019-05-14       Impact factor: 2.258

4.  Summer Hospitalization and Bronchial Asthma Make Treatment of Respiratory Syncytial Virus Infection Difficult: A Retrospective Study in Japan.

Authors:  Kosuke Oikawa; Hirotaka Ochiai; Kazuhiko Matsuhashi; Motoichiro Sakurai; Manabu Suzuki; Masaya Koganesawa; Tomomasa Terada; Yoko Ishii; Akatsuki Kokaze; Katsumi Mizuno
Journal:  Glob Pediatr Health       Date:  2022-05-17

5.  Transient occult cardiotoxicity in children receiving continuous beta-agonist therapy.

Authors:  Christopher L Carroll; Melinda Coro; Allison Cowl; Kathleen A Sala; Craig M Schramm
Journal:  World J Pediatr       Date:  2014-03-06       Impact factor: 2.764

6.  Bronchodilatory effect of inhaled budesonide/formoterol and budesonide/salbutamol in acute asthma: a double-blind, randomized controlled trial.

Authors:  Jenish J Arun; Rakesh Lodha; Sushil K Kabra
Journal:  BMC Pediatr       Date:  2012-03-07       Impact factor: 2.125

7.  Fluid Balance Is Associated with Clinical Outcomes and Extravascular Lung Water in Children with Acute Asthma Exacerbation.

Authors:  David B Kantor; Eliotte L Hirshberg; Molly C McDonald; John Griffin; Tess Buccigrosso; Nicole Stenquist; Craig D Smallwood; Kyle A Nelson; David Zurakowski; Wanda Phipatanakul; Joel N Hirschhorn
Journal:  Am J Respir Crit Care Med       Date:  2018-05-01       Impact factor: 30.528

8.  Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks.

Authors:  Noriyuki Yanagida; Morimitsu Tomikawa; Akinori Shukuya; Masamichi Iguchi; Motohiro Ebisawa
Journal:  World Allergy Organ J       Date:  2015-05-05       Impact factor: 4.084

Review 9.  Paediatrics: how to manage acute asthma exacerbations.

Authors:  James S Leung
Journal:  Drugs Context       Date:  2021-05-26

10.  A pilot study to evaluate the role of circulation CD4+ CCR6+ CRTh2+ cell in predicting risk of asthma in wheezing children.

Authors:  Jingyang Li; Jinhong Wu; Haipei Liu; Li Hua; Quanhua Liu; Dingzhu Fang; Yi Chen; Ruoxu Ji; Jianhua Zhang; Wenwei Zhong
Journal:  BMC Pediatr       Date:  2021-06-05       Impact factor: 2.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.